跳至主要内容
临床试验/NCT00788281
NCT00788281Unknown2 期

A Multi-Center Randomised Controlled Study to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
2 期
入组人数
200
试验地点
1
主要终点
disease free survival rate

研究概览

简要总结

Laparoscopic surgery has been widely accepted for its minimal invasion and safety. However, whether it has the same survival benefit as the traditional open surgery in Chinese population is still unknown. So we designed this study to evaluate the 3 year disease free survival rate in the laparoscopic group versus the open surgery group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent
  • Pathologically confirmed adenocarcinoma
  • Pre-surgery image staging as (CT/MRI):T2-3,N0-2,M0,(TNM stage,AJCC,version of 2003)
  • Single tumor locating at cecum, ascending colon, descending colon, sigmoid colon, rectosigmoid junction, rectum(distance from anal verge more than 7cm)
  • Tumor diameter less than 6cm
  • Age 18-75 year
  • Predicted survival longer than 6 months
  • Normal liver, renal, bone marrow function: (GPT less than 2 ULN,total bilirubin less than 1.5mg/dl,Cr less than 1.5 ULN,WBC more than 4×109/L,PLT more than 100×109/L)
  • No previous history of gastrointestinal surgery
  • No previous history of chemotherapy or radiotherapy
  • Exclusion criteria
  • Severe and uncontrolled medical disease including unstable angina pectoris, cardiac infarction and cerebral attack in 6 months
  • Could not tolerant general anesthesia or surgery for other organ dis-function
  • Allergy to chemotherapeutical agents in the protocol
  • History of other malignant tumor within 5 years
  • Severe mental disorder
  • Continued systematic steroid therapy
  • Woman during pregnancy or lactation
  • Under study of other clinical trial
  • No compliance of the protocol
  • Discovery of distant metastasis during surgery
  • Postsurgery stage of I or IV tumors

排除标准

  • 未提供

结局指标

主要结局

disease free survival rate

时间窗: 3 year

tumor residual rate of LRM and CRM

时间窗: 1 week

operation mortality

时间窗: 2 months

次要结局

  • survival rate(5 year)
  • local recurrence rate(5 year)
  • operation time(at the end of operation)
  • blood lost(during operation)
  • analgesic dosage(1,2 and 3 days post surgery)
  • evacuating time(post surgery)
  • operation morbidity(2 months)
  • transfer to open surgery(during operation)
  • fee(peri-operation)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验